02/27/2026
In patients with Huntington disease, treatment with vesicular monoamine transporter 2 inhibitors (VMAT2is) improved chorea, with no significant changes in adverse effects or depressive symptoms. VMAT2is may be a promising and safe treatment option for the disease: https://hubs.la/Q0443SJv0